Ideal Candidates Adults with significant weight to lose represent the primary target population for this combination
This substance has been shown to be very effective at managing Type 2 diabetes and losing weight
Dundon WG, Polenghi A, Guidice Del, Rappuoli G, Montecucco R
( Lancet 2023, NCT04982575 [12] ) randomised 92 adults with type 2 diabetes on metformin, with or without an SGLT2 inhibitor, 1:1:1 to CagriSema (n=31), semaglutide (n=31), or cagrilintide (n=30), all escalated to 2.4 mg, across 17 US sites over 32 weeks
Canadian-Specific Considerations For Canadians running this stack, seasonal adjustments are worth thinking about
Cera Alba is the white, bleached form of this ingredient